{"changes":[{"companyHref":"/c/nchromabio-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"nchromabio.com","fact":"company:added","name":"nChroma Bio","new":"added","old":"","publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"nchromabio-com","status":"sourced","url":"https://whoraisedwhat.com/c/nchromabio-com"}],"country":"","description":"Best-in-class epigenetic editing & targeted in vivo delivery technology to reach the full potential of genetic medicines","domain":"nchromabio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":["atlas-venture"],"lat":null,"lng":null,"location":null,"name":"nChroma Bio","nameSource":{"publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},"people":[],"rounds":[],"slug":"nchromabio-com","sources":[{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":null,"techStack":[],"totalRaisedUsd":null,"updatedAt":"2026-10-03"}